Korsana Biosciences, Inc. SEC filings KRSA
Korsana Biosciences, Inc. has 391 filings in SEC EDGAR's recent list, going back to Oct 9, 2018. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Filing | Aug 25, 2026 | — |
| 425 | Filing | Aug 12, 2026 | — |
| 425 | Filing | Aug 10, 2026 | — |
| 425 | Filing | Aug 6, 2026 | — |
| 425 | Filing | Aug 3, 2026 | — |
| EFFECT | Filing | Jul 24, 2026 | — |
| 425 | Filing | Jul 10, 2026 | — |
| 425 | Filing | Apr 1, 2026 | — |
| EFFECT | Filing | May 15, 2025 | — |
| CORRESP | Letter to the SEC | May 13, 2025 | — |
| UPLOAD | Letter from the SEC | May 12, 2025 | — |
| EFFECT | Filing | Feb 12, 2025 | — |
| CORRESP | Letter to the SEC | Feb 10, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 28, 2023 | — |
| CORRESP | Letter to the SEC | Dec 12, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 28, 2023 | — |
| D | Filing | May 25, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 7, 2021 | — |
| CORRESP | Letter to the SEC | Aug 27, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 24, 2021 | — |
| EFFECT | Filing | Jun 23, 2021 | — |
| CORRESP | Letter to the SEC | Jun 21, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2021 | — |
| D | Filing | Jun 17, 2021 | — |
| EFFECT | Filing | Aug 14, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 12, 2020 | — |
| CORRESP | Letter to the SEC | Aug 12, 2020 | — |
| D | Filing | Aug 11, 2020 | — |
| EFFECT | Filing | Jul 31, 2020 | — |
| CORRESP | Letter to the SEC | Jul 30, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2020 | — |
| EFFECT | Filing | Apr 23, 2019 | — |
| CORRESP | Letter to the SEC | Apr 22, 2019 | — |
| D | Filing | Apr 17, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2019 | — |
| DRS | Filing | Apr 9, 2019 | — |
| SEC STAFF ACTION | Filing | Mar 14, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 14, 2019 | — |
| CERT | Filing | Mar 14, 2019 | — |
| CORRESP | Letter to the SEC | Mar 12, 2019 | — |
| 10-12B/A | Filing | Mar 11, 2019 | — |
| 10-12B/A | Filing | Mar 4, 2019 | — |
| 10-12B | Filing | Jan 28, 2019 | — |
| DRSLTR | Filing | Jan 7, 2019 | — |
| DRS/A | Filing | Jan 7, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 18, 2018 | — |
| DRSLTR | Filing | Dec 6, 2018 | — |
| DRS/A | Filing | Dec 6, 2018 | — |
| UPLOAD | Letter from the SEC | Nov 6, 2018 | — |
| DRSLTR | Filing | Oct 9, 2018 | — |
| DRS | Filing | Oct 9, 2018 | — |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KRSA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Waltham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1755237
- Former names
- Cyclerion Therapeutics, Inc. (until Aug 27, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.